Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-076622
Filing Date
2011-08-12
Accepted
2011-08-12 13:03:34
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f59324e10vq.htm 10-Q 380837
2 EX-31.1 f59324exv31w1.htm EX-31.1 5655
3 EX-31.2 f59324exv31w2.htm EX-31.2 5626
4 EX-32.1 f59324exv32w1.htm EX-32.1 4409
  Complete submission text file 0000950123-11-076622.txt   1663990

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT ecyt-20110630.xml EX-101.INS 161257
6 EX-101 SCHEMA DOCUMENT ecyt-20110630.xsd EX-101.SCH 11876
7 EX-101 CALCULATION LINKBASE DOCUMENT ecyt-20110630_cal.xml EX-101.CAL 29450
8 EX-101 LABELS LINKBASE DOCUMENT ecyt-20110630_lab.xml EX-101.LAB 128146
9 EX-101 PRESENTATION LINKBASE DOCUMENT ecyt-20110630_pre.xml EX-101.PRE 83182
10 EX-101 DEFINITION LINKBASE DOCUMENT ecyt-20110630_def.xml EX-101.DEF 28390
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 111030318
SIC: 2834 Pharmaceutical Preparations